Literature DB >> 16905751

Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome.

J Kwan1, P Hand.   

Abstract

BACKGROUND: A significant proportion of acute stroke patients suffer neurological deterioration during the first few days of recovery. AIM: To explore the frequency, clinical characteristics, and consequences of early neurological deterioration during the acute recovery period.
METHODS: We assessed all consecutive patients admitted to a University hospital with suspected stroke. We recorded the following on admission: baseline characteristics, physiological parameters and laboratory results. On day 5 we recorded occurrence of complications, and functional outcome. Early neurological deterioration was defined as an increase in National Institute of Health Stroke Score (NIHSS) by two or more points (or stroke-related death) between admission and day 5.
RESULTS: We recruited 188 stroke patients, of whom 36 (19%) suffered early neurological deterioration. Patients with early neurological deterioration were significantly more likely to: (i) arrive at the hospital earlier (median 2.25 vs. 7.2 h, p = 0.015); (ii) have a history of atrial fibrillation (33% vs. 16%, p = 0.039); (iii) be current non-smokers (24% vs. 11%, p = 0.041); (iv) have a severe stroke-more total anterior circulation strokes (67% vs. 26%, p < 0.001) and worse NIHSS and GCS scores; (v) have intracerebral haemorrhage (22% vs. 7%, p = 0.011); (vi) have higher serum urea (mean 7.8 vs. 6.5 mmol/l, p = 0.035) and leukocyte count (mean 12.6 vs. 9.7 x 10(9)/l, p = 0.044); and (vi) die in hospital (44% vs. 10%, OR 12.8, 95%CI 3.8-43.1, p < 0.001). DISCUSSION: Early neurological deterioration is a frequent and important complication in acute stroke, with a poor short-term prognosis. Effective treatment strategies are urgently needed to reduce its occurrence and impact on recovery.

Entities:  

Mesh:

Year:  2006        PMID: 16905751     DOI: 10.1093/qjmed/hcl082

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  42 in total

1.  What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-21       Impact factor: 2.136

2.  Time to Neurological Deterioration in Ischemic Stroke.

Authors:  James E Siegler; Karen C Albright; Alexander J George; Amelia K Boehme; Michael A Gillette; Andre D Kumar; Monica Aswani; Sheryl Martin-Schild
Journal:  Med Student Res J       Date:  2017

3.  Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage.

Authors:  Wei Sun; Amanda Peacock; Jane Becker; Barbara Phillips-Bute; Daniel T Laskowitz; Michael L James
Journal:  J Clin Neurosci       Date:  2012-06-16       Impact factor: 1.961

4.  Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke.

Authors:  Anuradha Bharosay; Vivek Vikram Bharosay; Meena Varma; Kiran Saxena; Ajoy Sodani; Ravi Saxena
Journal:  Indian J Clin Biochem       Date:  2011-11-08

5.  Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients.

Authors:  Amelia K Boehme; Andre D Kumar; Adrianne M Dorsey; James E Siegler; Monica S Aswani; Michael J Lyerly; Dominique J Monlezun; Alexander J George; Karen C Albright; Timothy M Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-08-15       Impact factor: 2.136

6.  Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.

Authors:  Andre D Kumar; Amelia K Boehme; James E Siegler; Michael Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-30       Impact factor: 2.136

7.  Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-16       Impact factor: 2.136

8.  Can early ischemic lesion recurrence on diffusion-weighted MRI affect functional outcome after acute ischemic stroke?

Authors:  Wook-Joo Kim; Jae Hyoung Kim; Youngchai Ko; Jung Hyun Park; Mi Hwa Yang; Myung Suk Jang; Moon-Ku Han; Sang Yun Kim; Seong Ho Park; Hee-Joon Bae
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

9.  The Utility of Quantifiable Neurologic Assessments After Stroke: In response to Marsh et al, "The NIH Stroke Scale Has Limited Utility in Accurate Daily Monitoring of Neurologic Status".

Authors:  James E Siegler
Journal:  Neurohospitalist       Date:  2016-04-05

10.  A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke.

Authors:  James E Siegler; Amelia K Boehme; Karen C Albright; Alexander J George; Dominique J Monlezun; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-07-16       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.